fig6

From: Galacto-oligosaccharides alone and combined with lactoferrin impact the Kenyan infant gut microbiota and epithelial barrier integrity during iron supplementation in vitro

Galacto-oligosaccharides alone and combined with lactoferrin impact the Kenyan infant gut microbiota and epithelial barrier integrity during iron supplementation <i>in vitro</i>

Figure 6. Quantification of total and intermediate metabolites and SCFA after treatment with iron and GOS with/without bLF in PolyFermS. Mean ± SD of metabolite concentration is shown for the last three days of stabilization (STAB) and the last three days of treatment (TREAT) of (A) two experimental periods of donor 4 and (B) three experimental periods of donor 5. Significant differences between STAB and TREAT in the corresponding periods are indicated. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001, ^****P < 0.0001. SCFA: Short-chain fatty acid; GOS: galacto-oligosaccharides; bLF: bovine lactoferrin.